Ruth Hardiman v. HHS - Influenza, chronic inflammatory demyelinating polyneuropathy (CIDP) (2022)
Case summary [AI summaries can sometimes make mistakes]
Ruth Hardiman filed a petition on June 15, 2020, alleging that an influenza vaccine administered on October 16, 2018, caused her to develop chronic inflammatory demyelinating polyneuropathy (CIDP). The respondent denied that the vaccine caused CIDP or any other injury.
The parties reached a stipulation recommending an award of compensation. The Special Master found the stipulation reasonable and adopted it as the decision of the Court.
Ruth Hardiman was awarded a lump sum of $160,000.00, payable by check to petitioner, for all damages available under 42 U.S.C. § 300aa-15(a). The parties agreed to expedite the entry of judgment by renouncing the right to seek review.
Petitioner was represented by Amy A. Senerth of Muller Brazil, LLP, and respondent was represented by Althea W.
Davis of the U.S. Department of Justice.
The decision was issued by Special Master Nora Beth Dorsey.
Theory of causation
Petitioner Ruth Hardiman alleged that an influenza vaccine administered on October 16, 2018, caused her to develop chronic inflammatory demyelinating polyneuropathy (CIDP). Respondent denied causation. The parties reached a stipulation for compensation. The public decision does not describe the specific theory of causation, medical experts, clinical details, onset, symptoms, tests, treatments, or the mechanism of injury. The Special Master Nora Beth Dorsey adopted the stipulation, awarding petitioner a lump sum of $160,000.00 for all damages. Petitioner's counsel was Amy A. Senerth, and respondent's counsel was Althea W. Davis. The decision was filed on December 7, 2021, and entered on January 4, 2022.
Source PDFs
USCOURTS-cofc-1_20-vv-00719